Myocardial Blood Volume Is Associated With Myocardial Oxygen Consumption An Experimental Study With Cardiac Magnetic Resonance in a Canine Model by McCommis, Kyle S. et al.
TM
M
A
K
B
J
S
U
i
n
d
i
r
a
t
©
M
o
o
d
y
r
T
a
d
M
p
s
M

c
r
F
S
H
i
M
J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 2 , N O . 1 1 , 2 0 0 9
© 2 0 0 9 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 8 X / 0 9 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . D O I : 1 0 . 1 0 1 6 / j . j c m g . 2 0 0 9 . 0 7 . 0 1 0E C H N O L O G Y O N T H E V E R G E O F T R A N S L A T I O N
yocardial Blood Volume Is Associated With
yocardial Oxygen Consumption
n Experimental Study With Cardiac Magnetic Resonance in a Canine Model
yle S. McCommis, BS,* Haosen Zhang, PHD,* Thomas A. Goldstein, MS,*
ernd Misselwitz, PHD,‡ Dana R. Abendschein, PHD,† Robert J. Gropler, MD,*
ie Zheng, PHD*
t. Louis, Missouri; and Berlin, Germany
nderstanding the oxygen consumption of the left ventricular myocardium provides important insight
nto the relationship between myocardial oxygen supply and demand. In other territories, cardiac mag-
etic resonance has been utilized tomeasure myocardial oxygen consumption with a blood level oxygen
ependent (BOLD) technique. The BOLD technology requires repetitive sampling of stationary tissues and
s frequently implemented in areas such as the brain. A limitation to utilizing BOLD cardiac magnetic
esonance techniques in theheart has been cardiacmotion. In this study,wedocument amethodology for
cquiring BOLD images in the heart and demonstrate the utility of the technique for identifying associa-
ions betweenmyocardial oxygen consumption and blood flow. (J AmColl Cardiol Img 2009;2:1313–20)
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rma,yocardial ischemia occurs when the supply of
xygen is inadequate for the metabolic demand
f the myocardium. Measurements of myocar-
ial perfusion (O2 supply) and myocardial ox-
gen consumption (MVO2) may provide accu-
ate assessments of this balance in the heart.
wo important parameters for oxygen delivery
re myocardial blood flow (MBF) and myocar-
ial blood volume (MBV). The addition of
BV measurements increases the accuracy of
erfusion assessments because MBV has been
hown to be altered in situations of increased
VO2 (1). The MBV is composed of vessels
200 m, of which 90% are capillaries. Be-
ause only50% of capillaries are functional at
est, altering the amount of functional capillar-
rom the *Mallinckrodt Institute of Radiology and †Cardiovascular
t. Louis, Missouri; and ‡Bayer Schering Pharma AG, Berlin, Ge
L74019-01. Dr. Misselwitz is an employee of Bayer Schering Pha
n this study.anuscript received March 11, 2009; revised manuscript received Junees can drastically change the tissue oxygen-
tion levels.
Positron emission tomography (PET) is cur-
ently the only imaging modality capable of ab-
olute quantification of regional myocardial per-
usion and oxygen metabolism. The use of PET
ermits the accurate quantification of MBF with
5O-water and MVO2 with
11C-acetate. How-
ver, low spatial resolution, relatively long acqui-
ition times, limited availability, relatively high
ost, and ionizing radiation discourage the wide-
pread use of PET for these purposes. Further-
ore, PET cannot measure MBV. Myocardial
ontrast echocardiography (MCE) has the capa-
ility of measuring MBF and MBV but not
VO2.
ision, Washington University School of Medicine,
ny. This work was supported by NIH grant R01
which produces the Gadomer contrast agent used16, 2009, accepted July 29, 2009.
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1314Cardiac magnetic resonance (CMR) is a nonin-
asive imaging modality that provides excellent
mage spatial resolution and soft-tissue contrast,
oes not require ionizing radiation, and is widely
vailable. CMR can measure absolute MBF and
BV via first-pass methods (2) and the oxygen
xtraction fraction (OEF) by the use of the blood
xygen level-dependent (BOLD) technique (3).
ick’s law states that MVO2  MBF  OEF;
herefore, CMR also can provide an estimation of
VO2. The objective of this study was to apply
hese comprehensive CMR techniques to evaluate
BF, MBV, OEF, and MVO2 in a canine model
ith control, moderate (75%), and severe (86% to
5%) coronary artery stenosis during dipyridamole
or dobutamine hyperemia. We hypothe-
size that direct measurements of these
parameters by CMR will facilitate a com-
prehensive ischemic assessment.
M E T H O D S
Animal preparation. All animal procedures
were approved by the Animal Studies
Committee at Washington University. A
total of 21 (weight 24.7 3.0 kg) mongrel
dogs were used, and they were divided into
6 groups (Table 1). A thoracotomy was
performed in the fourth intercostal space
and the pericardium incised. The left an-
terior descending coronary artery (LAD)
was dissected free distal to the first diag-
onal branch. The artery was instrumented
in a proximal-distal order with a Doppler
flow probe, a pneumatic occluder, and a
CMR-compatible stenosis clamp. The
procedure for setting the stenosis severity
has been described previously. Serial 20-s
occlusions were performed to delineate the
yperemic flow responses. After tightening the
tenosis clamp, another occlusion was performed to
ssess the decrease in hyperemic flow. After attain-
ng the desired level of stenosis defined by reduction
n hyperemic flow, the occluder was removed. The
ogs remained open-chest and were moved to the
agnetic resonance imaging suite. Control dogs
ere omitted from thoracotomy surgery.
CMR was performed at rest and during
ipyridamole-induced vasodilation or dobutamine-
nduced hyperemia. Dipyridamole (Bedford Labo-
atories, Bedford, Ohio) was injected intravenously
t a dose of 0.14 mg/kg/min for 4 min. Dobutamine
ing
ry
wHospira Inc., Lake Forest, Illinois) was started at 5 tg/kg/min and titrated at 5-g/kg/min increments
very 5 min until heart rate reached 130 beats/
in (maximum of 30 g/kg/min).
MR imaging. Study timeline is shown in Figure 1.
maging was performed on a 1.5-T Sonata scanner
Siemens Medical Solutions, Erlanger, Germany).
4-element phased array coil placed around the
hest was used for signal reception, and a body coil
as used as a transmitter. Scout imaging was
erformed to obtain a short-axis image of the left
entricle (LV) at the middle level of the papillary
uscles. During scans, respiratory motion was re-
uced by turning off ventilation to simulate breath
olding.
IRST-PASS PERFUSION CMR PROTOCOL. Images
uring the bolus injection of Gadomer (Bayer
chering Pharma AG, Berlin, Germany), an intra-
ascular contrast agent, were sequestered by a
aturation-prepared turbo fast low-angle shot se-
uence. The short-axis slice of the LV was acquired
uring mid-diastole, triggered by the R-wave of the
lectrocardiogram. A total of 60 to 80 dynamic
mages were gathered, and images were collected at
very RR interval. Other imaging parameters in-
luded the following: time of repetition  2.5 ms;
ime of echo  1.2 ms; time of inversion  90 ms;
ip angle  18°; field of view  220  138 mm2;
atrix size  128  80%; slice thickness  8 mm;
nd image acquisition time window per cardiac
ycle  150 ms.
ROTOCOL FOR BOLD CMR. The BOLD effect was
etected by a multicontrast 2-dimensional seg-
ented turbo spin-echo sequence. Double
nversion-recovery preparation yielded black-blood
mages. The sequence was triggered by electrocar-
iogram with the turbo spin-echo train placed in
id-diastole to minimize cardiac motion and
atch the first-pass perfusion images. Parameters
ncluded the following: field of view  220  131
m2; matrix size 256  156; slice thickness  8
m; inversion time 350 to 500 ms, depending on
Table 1. Treatment Groups
Group # (n) Stenosis, Area (%) Pharmacologic Stressor
1 (4) 0 Dipyridamole
2 (4) 86 Dipyridamole
3 (3) 95 Dipyridamole
4 (4) 0 Dobutamine
5 (3) 75 Dobutamine
6 (3) 86–95 DobutamineB B R E V I A T I O N S
N D A C R O N YM S
OLD blood oxygen
evel-dependent
MR cardiac magnetic
esonance
AD left anterior descend
oronary artery
CX left circumflex corona
rtery
V left ventricle
BFmyocardial blood flo
BVmyocardial blood
olume
CEmyocardial contrast
chocardiography
VO2myocardial oxygen
onsumption
EF oxygen extraction
raction
ET positron emission
omographyhe RR interval; and data acquisition time  24 
R
T
T
t
1
w
m
i
I
i
V
c
s
a
a
(
M
t
i
t
w
M
N
m
t
h
d
fi
i
a
s
w
s
m
C
w
F
T
c

D
d
c
p
b
s
r
a
t
a
d
R
H
c
s
w
i
A
a
f
r
a
a
a
(
d
t
L
a
i
M
a
d
a
s
d
n
w
s
V
M
a
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 2 , N O . 1 1 , 2 0 0 9
N O V E M B E R 2 0 0 9 : 1 3 1 3 – 2 0
McCommis et al.
Regional Myocardial Perfusion and Oxygenation by CMR
1315R, or 14.4 s for a typical 600-ms RR interval.
hree echo times, TE1  24, TE2  48, and
E3 72, were used. At rest, this sequence was run
wice with 2 different echo spacings (  8 and  
2) and at   8 during hyperemia. The 2 T2 maps
ith 2 echo spacings at rest were used to determine
odel parameters for the calculation of OEF dur-
ng hyperemia.
MAGE POST-PROCESSING. First-pass perfusion
mages were analyzed with a JAVA program (Java
5.0, Sun Microsystems, Santa Clara, California)
reated in our lab. Images were denoised and
ubjected to a validated perfusion quantification
lgorithm (2). This algorithm created both MBF
nd MBV maps, on which regions of interest
ROIs) could be drawn. We determined MBV by
BF divided by mean transit time. The mean
ransit time was determined by the area under the
mpulse curve, and images before the second con-
rast pass were removed. Details of this estimation
ere shown in a previous report.
We analyzed BOLD T2-weighted images with a
ATLAB graphics program (The MathWorks,
atick, Massachusetts). Pixel-by-pixel maps of the
yocardial T2 decay constants were calculated from
he signal intensities, and then OEF maps during
yperemia were determined with our previously
escribed model (3), on which ROIs similar to the
rst-pass perfusion map ROIs were drawn. A rest-
ng OEF of 0.6 was assumed, which is based on
rterial and coronary sinus blood sampling mea-
urements in control dogs at rest (R2  0.90), as
ell as PET measurements in dogs with moderate
tenosis (R2  0.75). Sample perfusion and OEF
aps are shown in Figure 2.
ALCULATION OF MVO2. Once MBF and OEF
ere determined, MVO2 was calculated using
ick’s law:
MVO2 [O2]aOEFMBF (1)
he constant [O2]a is defined as the total oxygen
ontent of arterial blood, and a value of 7.99
mol/ml was used.
ata analysis. The MBF, MBV, OEF, and MVO2
ata are presented as mean  SD. Percentage
hange (from rest to hyperemia) was determined. A
aired and unpaired t test was used to compare
etween rest and pharmacologic stress and between
tenosed and control dogs, respectively. Linear cor-
elations between these parameters were expressed es the coefficients of determination. Comparison
ests between 2 R2 values were performed by use of
Z test. A p value 0.05 signified significant
ifferences.
E S U L T S
emodynamics. Table 2 displays the hemodynamic
hanges. As expected, dipyridamole caused only
light changes in rate-pressure product (p  NS),
hereas dobutamine produced significant increases
n rate-pressure product (p  0.05).
bsolute MBF and MBV values. The absolute MBF
nd MBV values, as well as percent change values
or all groups, are displayed in Tables 3 and 4,
espectively. During dipyridamole, control dogs
chieved 2- to 3-fold increases in MBF. Stenosis
ttenuated these MBF reserves in the LAD region
nd in the remote left circumflex coronary artery
LCX) region with severe 95% LAD stenosis. The
obutamine groups had similar trends in MBF. The
rend for attenuation of increased MBF in the remote
CX region was not statistically significant but is in
greement with other reports.
In control dogs, dipyridamole and dobutamine
nduced moderate 30% and 50% changes in
BV, respectively. Stenosis 86% dramatically
ttenuated the MBV increases in the LAD region
uring either dipyridamole vasodilation or dobut-
mine hyperemia. Such attenuation also was ob-
erved in the remote LCX region, especially with
obutamine injection. However, for 75% area ste-
osis during dobutamine, the attenuation of MBV
as much less, although significant changes were
till observed relative to the resting values.
alues for OEF and MVO2. The hyperemic OEF and
VO2 values, as well as the percent change values,
re presented in Tables 5 and 6, respectively. As
Stenosis Created
Anesthesia
BOLD
Imaging
First-pass
Perfusion
BOLD
Imaging
First-pass
Perfusion E
Pharmacologic
Stressor Started
10-2010-20 2-3 2-350 Tim
Figure 1. Imaging Study Protocol
The blood oxygen level-dependent (BOLD) method was used to ev
the myocardial oxygen extraction fraction, and ﬁrst-pass perfusion w
to evaluate both myocardial blood ﬂow and volume. The BOLD and
pass perfusion scans were performed at rest and during either intra
dipyridamole or dobutamine hyperemia. The numbers below the lin
sent the approximate time in minutes between events.KC1
uthanasia
e (min)
aluate
as used
ﬁrst-
venous
e repre-xpected, in control dogs dipyridamole caused large
d
s
d
b
p
O
r
3
s
L
r
c
c
L
R
g
v
w
L
t
s
r
i
s
M
s
p
m
d
c
a
s
c
r
d
M
v
t
M
w
c
s
D
T
v
m
d
t
M
s
d
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 2 , N O . 1 1 , 2 0 0 9
N O V E M B E R 2 0 0 9 : 1 3 1 3 – 2 0
McCommis et al.
Regional Myocardial Perfusion and Oxygenation by CMR
1316ecreases in OEF. These decreases also were ob-
erved in the remote normal LCX regions of the
Figure 2. Representative Short-Axis Maps From a Dog With a
96% LAD Stenosis During Dipyridamole
The myocardial blood ﬂow map (A) and myocardial blood vol-
ume map (B), derived from the ﬁrst-pass perfusion images,
clearly show an anterior perfusion defect. The extraction fraction
map (C), derived from the blood oxygen level-dependent
T2-weighted images, shows greater extraction fraction in the
stenotic anterior region as the result of the decreased oxygen
supply. The stenotic LAD region is marked with a yellow region
of interest. The myocardial blood ﬂow scale units are ml/min/g
(A); myocardial blood volume scale units are ml/g (B). LAD 
left anterior descending; LV  left ventricle.ogs with coronary stenosis. Dobutamine increased toth MVO2 and MBF, which in control dogs
roduced no significant change in OEF. Only small
EF changes were observed in the stenotic and
emote regions.
In control dogs, dipyridamole caused moderate
0% to 70% increases in MVO2 (4). The LAD
tenosis attenuated the MVO2 increases in the
AD- and LCX-perfused regions. Dobutamine
esulted in significantly larger increases in MVO2 in
ontrol dogs. However, even 75% stenoses signifi-
antly reduced the change in MVO2 in both the
AD- and LCX-perfused regions.
elationship between myocardial perfusion and oxy-
en utilization. Correlations between MVO2 reserve
ersus MBF or MBV reserve for dogs with and
ithout coronary artery stenosis in the LAD and/or
CX (in control dogs) subtended regions are plot-
ed in Figure 3. In control dogs, MBV reserve
hows mild-to-moderate correlation with MVO2
eserve with dobutamine stress but not with dipyr-
damole vasodilation (Fig. 3A). In dogs with steno-
is, MBF reserve appears to correlate well with
VO2 reserve, and similar correlations were ob-
erved between dipyridamole and dobutamine hy-
eremia. With stenosis, MBV reserve again appears
uch less correlated with MVO2 during dipyri-
amole vasodilation. However, with the larger in-
reases in MVO2 with dobutamine, MBV reserve
ppears to be strongly correlated with MVO2 re-
erve, although the p values for the correlation
oefficients were not statistically different as the
esult of limited data points. It is noted that during
obutamine, the slope of MBV reserve versus
VO2 reserve is also greater than MBF reserve
ersus MVO2 reserve, indicating a better associa-
ion with MBV reserve. From this point of view,
BV may be a significant source of O2 supply
hen MBF supply becomes exhausted with in-
reased O2 demand in settings of coronary artery
tenosis.
I S C U S S I O N
he purpose of this study was to apply our nonin-
asive CMR techniques to directly assess regional
icrocirculatory changes that occur during dipyri-
amole and dobutamine stress. To our knowledge,
his is the first study to show that regional MBF,
BV, OEF, and MVO2 can be assessed noninva-
ively in a single imaging session. The role of MBV
uring increased O2 demand is also confirmed in
his study.
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1317ogs during dipyridamole. By using blood sampling
echniques in control dogs, Hoffman et al. (4)
bserved MVO2 increases of 70% with adenosine
asodilation, which is comparable with our 30% to
0% increases in MVO2 using dipyridamole. In
omparison with the control groups, resting MBF
f LAD regions in the 86% and 95% stenosis
roups significantly reduced 38% (p  0.01) and
2% (p  0.02), respectively. However, after nor-
alizing the resting MBF by rate-pressure product,
here is no statistical difference between control and
Table 2. Hemodynamics for Control and Stenosed Dog Groups
Control Dogs
HR SBP RPP
Rest 93.5 6.1 78.7 15.5 7,356.5 1,
DIP 91.7 11.9 77.8 22.0 7,181.6 2,
DOB 113.8 18.9* 111.0 28.8* 13,006.1 5,
∆ DIP (%) 2.4 12.8 6.7 12.1 9.4 18
∆ DOB (%) 21.1 23.4 39.1 25.3 72.7 62
Values presented as mean  SD. *p  0.05 for stress versus rest. †p  0.05 fo
DIP  dipyridamole; DOB  dobutamine; HR  heart rate; RPP  rate pressu
Table 3. Myocardial Blood Flow (ml/min/g)
Group Stenosis LAD LCX
1 Control
Rest 1.0 0.2 1.0 0.2
DIP 2.9 0.8* 3.1 0.6*
% change 198.9 29.7 231.2 53.1
2 86%
Rest 0.6 0.1† 1.1 0.3
DIP 0.8 0.1† 3.1 0.6*
% change 29.1 4.1† 200.8 75.3
3 95%
Rest 0.6 0.1† 1.5 0.5
DIP 0.6 0.2† 3.6 1.1*
% change 11.9 6.9† 139.7 50.8‡
4 Control
Rest 1.1 0.3 1.0 0.3
DOB 3.0 0.6* 3.0 0.6*
% change 191.6 69.0 204.4 75.3
5 75%
Rest 0.8 0.0 1.2 0.3
DOB 1.2 0.1† 4.3 0.8*
% change 55.0 11.7† 143.9 8.4
6 86%–95%
Rest 0.8 0.1 1.3 0.1
DOB 1.1 0.2† 2.8 1.0*
% change 40.0 10.5† 130.5 65.5
Myocardial blood ﬂow values presented as mean SD in ml/g/min; *p 0.05
for stress versus rest, †p  0.05 for control versus stenosis, ‡p  0.05 for
dipyridamole groups 2 versus 3, or for dobutamine groups 5 versus 6.
LAD  left anterior descending perfused region; LCX  left circumﬂexperfused region; other abbreviations as in Table 2.ither stenosis groups for the resting MBF (MBF/
ate-pressure product  104: 0.46  0.43 ml/g/min
n control vs. 0.78  0.09 ml/g/min in the 86%
tenosis group or vs. 0.61  0.24 ml/g/min in the
5% stenosis group). Similar decreases in MBF
eserve have been observed in dogs and clinically
ith MCE and PET. Although they showed
130% increases in MBF in normal regions of
nimals with stenosis (we showed 140% to 200%),
hey also observed only 24% increases in MBF in
he zone distal to the stenosis (we showed 12% to
Stenosed Dogs
HR SBP RPP
7 101.9 16.3 88.7 12.3 8,784.9 2,217.4
7 101.5 18.0 82.8 13.4 8,350.8 2,872.3
4* 138.7 18.3* 121.6 27.4* 1,7033.0 3,873.0*†
2.4 12.7 9.3 3.3 16.4 8.7
46.8 37.7† 39.5 33.1 114.8 83.5†
nosed versus control dogs.
roduct; SBP  systolic blood pressure; ∆  percent change.
Table 4. Myocardial Blood Volume (ml/100 g)
Group Stenosis LAD LCX
1 Control
Rest 5.9 0.9 5.6 1.0
DIP 7.8 1.2* 7.6 0.9*
% change 33.3 20.6 40.1 28.2
2 86%
Rest 4.0 1.1† 6.0 1.6†
DIP 4.7 1.3† 9.0 0.6*
% change 21.0 21.1 36.7 33.1
3 95%
Rest 3.7 0.4† 6.0 1.5
DIP 4.7 1.6† 9.0 1.5*
% change 22.8 28.8 53.0 24.5
4 Control
Rest 5.3 0.3 4.7 0.3
DOB 7.9 1.2* 7.7 1.4*
% change 50.8 29.9 60.4 21.0
5 75%
Rest 4.3 0.7 7.3 1.3†
DOB 7.0 2.4 10.6 0.7*†
% change 36.0 9.0 48.5 19.2
6 86%–95%
Rest 3.2 0.6† 6.2 0.9†
DOB 3.9 0.4† 7.4 0.8‡
% change 25.9 13.1†‡ 20.5 10.4†‡
Myocardial blood volume values presented as mean  SD in ml/100 g; *p 
0.05 for stress versus rest, †p  0.05 for control versus stenosis, ‡p  0.05 for
dipyridamole groups 2 versus 3 or for dobutamine groups 5 versus 6.528.
722.
343.
.5
.0
r steAbbreviations as in Tables 2 and 3.
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13189%). The changes in MVO2 in the LAD stenotic
egion during dipyridamole vasodilation were ob-
erved at a similar level for both 86% and 95%
evere stenosis.
It has been suspected that a primary method of
educing MBV is a reduction in perfusion bed size.
hese data support the notion that MBV plays a
ediating role in the match/mismatch of MBF and
VO2 (1). Our MBV findings during dipyridam-
le conform to other reports (1) in that no signifi-
ant relationship exists between MBV and small
hanges in MVO2 caused by chronotropic stimula-
ion alone.
ogs during dobutamine. In control dogs, we ob-
erved 157% to 194% increases in MVO2 with
obutamine. This large O2 demand was accounted
or by 192% to 204% increases in MBF and 51% to
0% increases in MBV. These findings are similar
o Le et al. (1), who found 200% increases in
BF and 90% to 150% increases in MVO2 in
ormal dogs with varying dobutamine doses. With
5% area stenosis, the region distal to the stenosis
Table 5. Oxygen Extraction Fraction
Group Stenosis LAD LCX
1 Control
Rest 0.60 0.00 0.60 0.00
DIP 0.27 0.17* 0.32 0.12*
% change 54.5 28.7 46.9 19.7
2 86%
Rest 0.60 0.00 0.60 0.00
DIP 0.54 0.03† 0.31 0.09*
% change 12.9 5.4† 49.1 14.8
3 95%
Rest 0.60 0.00 0.60 0.00
DIP 0.60 0.02† 0.31 0.10*
% change 0.5 8.6† 48.6 16.3
4 Control
Rest 0.60 0.00 0.60 0.00
DOB 0.54 0.12 0.58 0.11
% change 10.2 19.7 2.6 18.2
5 75%
Rest 0.60 0.00 0.60 0.00
DOB 0.62 0.04 0.64 0.06
% change 3.0 7.5 7.3 10.6
6 86%–95%
Rest 0.60 0.00 0.60 0.00
DOB 0.57 0.04 0.49 0.06*‡
% change 5.6 6.8 17.6 10.4‡
Oxygen extraction fraction values presented as mean  SD; *p  0.05 for
stress versus rest, †p  0.05 for control versus stenosis, ‡p  0.05 for
dipyridamole groups 2 versus 3, or for dobutamine groups 5 versus 6.
Abbreviations as in Tables 2 and 4.ad dramatic attenuation of MVO2 increase. Thisnding was associated with a similar rate of reduc-
ion of MBF reserve in the stenotic LAD region,
nd OEF remained similar to rest. The MBV
ncrease was slightly attenuated in the 75% area
tenosis regions than in control dogs. With further
ncrease in stenosis severity, both MBF and MBV
eserve were attenuated, and OEF again remained
he same as at rest, resulting in less MVO2 increase.
imilar trends were observed in the remote LCX
egion.
A recent study (5) in which the authors used
adiolabeled microspheres in dogs showed the re-
ote regions of dogs with coronary stenosis had a
16% MBF increase, whereas the region distal to
he stenosis showed only a 20% increase in MBF.
y using blood sampling techniques, they also
howed large increases in MVO2 with dobutamine
efore stenosis (120%) and significantly attenuated
VO2 increases with dobutamine after stenosis
20%).
The MBV has a close relationship with MVO2
hen inotropic stimulation (as with dobutamine)
nduces relatively large changes in MVO2. This can
Table 6. Myocardial Oxygen Consumption Rate
Group Stenosis LAD LCX
1 Control
Rest 4.82 0.90 4.75 0.99
DIP 6.75 4.46* 8.35 3.64*
% change 33.5 75.9 73.9 55.8
2 86%
Rest 2.97 0.28† 5.38 1.57
DIP 3.32 0.29* 7.83 2.43*
% change 12.3 6.3 45.9 15.1
3 95%
Rest 2.78 0.59† 7.55 2.35
DIP 3.13 1.02* 8.84 2.51
% change 11.9 8.6 17.9 13.4‡
4 Control
Rest 5.18 1.14 4.97 1.19
DOB 13.41 4.77* 14.25 3.82*
% change 156.9 58.3 193.9 72.2
5 75%
Rest 3.75 0.19 8.61 1.26†
DOB 5.99 0.69*† 22.81 5.59*
% change 59.3 11.4† 162.3 33.5
6 86%–95%
Rest 3.98 0.67 6.21 0.57‡
DOB 5.23 0.73† 11.70 4.81*
% change 31.8 5.3†‡ 91.5 51.2†
Myocardial oxygen consumption values presented as mean  SD in
ml/kg/min; *p  0.05 for stress versus rest, †p  0.05 for control versus
stenosis, ‡p  0.05 for dipyridamole groups 2 versus 3, or for dobutamine
groups 5 versus 6.
Abbreviations as in Tables 2 and 4.
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cardial blood volume; MVO2  myocardial oxygen consumption.
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1319e observed from Figure 3; when MVO2 was only
oderately increased with dipyridamole, MBF re-
erve had a closer relationship to MVO2 reserve
han MBV reserve. When MVO2 was more signif-
cantly altered with dobutamine, MBV reserve was
ore closely associated with MVO2 reserve. These
esults are in agreement with MCE findings show-
ng that minor increases in MVO2 can be met by
ncreases in MBF alone but major MVO2 increases
equire increases in MBV as well.
tudy limitations. There are several factors that affect
hese quantification methods for OEF and MVO2.
irst, there is no CMR quantification method for
bsolute OEF at rest. Thus, we must assume a rest
EF of 0.6 and determine the hyperemic OEF based
n change in T2 during hyperemia. Although this may
nduce systematic errors, the hyperemic OEF was
losely correlated with other gold standards, either by
lood sampling (3) or by PET. Second, spatial reso-
ution and signal-to-noise ratio are limited to differ-
ntiate endomyocardium and epimyocardium. These
ransmural gradients in myocardial perfusion and ox-
genation are important for the diagnosis of myocar-
ial ischemia. Although MBF and MBV maps could
e analyzed for this purpose, the major limitation lies
n the OEF map that is created by a T2 map using a
-echo fitting procedure. Such a low number of
choes created “mapping noise” that caused a large
patial variation in T2. Other T2-weighted methods or
ore echo numbers may be needed to reduce the
oise. Finally, LV wall motion may hamper the
ccuracy of myocardial T2 measurement. Although
mages are acquired at mid-diastole, i.e., the relatively
otionless period within one cardiac cycle, we have
bserved LV motion among images with different
cho times. This cardiac motion often occurs with
ncreased heart rates during dobutamine hyperemia.
ecause we used double inversion recovery technique
o minimize blood flow signal in the LV, this cardiac
otion also reduced the efficiency of the blood flow
ignal suppression. Therefore, combined adverse ef-
ects of this motion may attenuate or lengthen the
cho train of the T2 decay curve. Given the com-
lexity of these motion effects, no simulation was
et performed to estimate the error from these
ffects. However, on the basis of our experience, the
ossible error could be up to 5% of the myocardial
2, which is close to the precision we observed in
ormal dogs (3). This would lead to an error of 14%
n the estimation of OEF. Efforts to reduce this
ardiac motion are one of our laboratory’s ongoingM
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Figure 3. Regression Analysis to Discern Relationships Among
MBF, MBV, and MVO2 Reserve During Dipyridamole or
Dobutamine
(A) Control dogs show only mild and moderate correlation
between MBV reserve and MVO2 reserve during dipyridamole
(DIP) (pink circles) and dobutamine (DOB) (green circles),
respectively. (B) In stenotic regions, MBF reserve is slightly more
correlated with MVO2 reserve during DIP (pink circles). (C) How-
ever, MBV reserve is more correlated with MVO2 reserve during
DOB (green circles). This ﬁnding supports the theory that MBV
is required during inotropic stimulation when MVO2 is more sig-
niﬁcantly increased. MBF  myocardial blood ﬂow; MBV  myo-rojects.
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1320O N C L U S I O N S
he combination of the CMR methods used in this
tudy facilitates the comprehensive evaluation of mi-
rocirculatory pathophysiology caused by coronary
tenosis. Notably, MBV appears to correlate with
ignificantly increased MVO2 in both normal and
schemic myocardial regions. Because even a moderate2008;59:1394–400. MHJ, Mansoor A, ZMBF and MBV) but also oxygen utilization (MVO2
nd OEF), it is important to be able to assess all these
arameters to evaluate myocardial ischemia.
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